(All fields required)
Please enter a valid email.
Please enter your name.
This study is a clinical trial funded by the Tourette Syndrome Association USA. The protocol uses repetitive transcranial magnetic stimulation to treat patients with moderate - severe tic disorder/Tourette Syndrome. This study is registered with ClinicalTrials.gov (http://clinicaltrials.gov/ct2/show/NCT01258790?term=wu+tourette&rank=1).
Funding Source: Tourette Syndrome Association USA
This NIH-funded study assesses and compares motor skill development in children ages 8 to 12 years old with ADHD as well as typically developing children. We are using transcranial magnetic stimulation (TMS) to identify abnormalities in brain excitability that correlate with ADHD symptoms.
Funding: National Institutes of Health R01 MH078160
Collaborator: Stewart Mostofsky, MD, Laboratory for Neurocognitive and Imaging Research, Baltimore
This NIH-funded study is evaluating motor cortex changes related to treatment with atomoxetine for ADHD symptoms in children. We are using TMS to study the brain before treatment and after one month of treatment with atomoxetine.
Funding: NIH R01 MH08185
Collaborator: Randy Sallee, MD, PhD, University of Cincinnati
This study is funded by the Tourette Syndrome Association USA and evaluates a long-term potentiation-like property in children and adults with Tourette syndrome. We are using a new TMS technique to study brain changes related to learning in the motor system in children and adults with Tourette syndrome as well as healthy children and adults.
Funding: Tourette Syndrome Association USA
This innovative study uses low-intensity TMS to try to improve speech in patients who have lost speech function due to strokes.
Funding: NINDS: R01NS048281
Principle Investigator: Jerzy Szaflarski, MD, PhD, University of Cincinnati Neuroscience Institute
This study aims to measure and quantify abnormalities in the surface of the brain that may correspond to learning and behavioral problems that sometimes occur in children with neurofibromatosis type 1 (NF1).
Funding: Cincinnati Children’s Hospital Medical Center pilot grant
This study uses localized TMS pulses to try to reduce anxiety in adolescents with obsessive compulsive disorder.
Lead investigator: Elana Harris, MD, PhD, Division of Child Psychiatry, Cincinnati Children’s
Donald L. Gilbert, MD, MS
Division of Neurolgy3333 Burnet Ave.MLC 11006Cincinnati, OH 45229Phone: 513-636-4222Fax: 513-636-3980Email: email@example.com
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the tri-state area? 1-877-881-8479
© 1999-2013 Cincinnati Children's Hospital Medical Center